1. A method for implementing call recording, wherein, an audio signal channel is established between a master processor and a slave processor of a mobile terminal; the method also comprises:
the slave processor sending a microphone’s sidetone signal and handset signal of the mobile terminal through the established audio signal channel;
the master processor receiving the sidetone signal and the handset signal and recording;
wherein said establishing the audio signal channel between the master processor and the slave processor of the mobile terminal is specifically:
the mobile terminal’s master handset being connected directly with the master processor’s multi-channel switch, and the mobile terminal’s headset being connected with the master processor’s multi-channel switch;
the slave processor’s first output port being connected with the master processor’s first audio input port to form a first audio signal channel; the slave processor’s second output port being connected with the master processor’s second audio input port, and the second audio input port being connected with the master processor’s multi-channel switch to form a second audio signal channel.
2. The method of claim 1, the slave processor sending a microphone’s sidetone signal and handset signal of the mobile terminal through the established audio signal channel is specifically:
using an analog switch to control the microphone connect with the slave processor, and the slave processor controlling the microphone’s sidetone signal output from the first output port or the second output port; the slave processor outputting the handset signal through the second output port.
3. The method of claim 1, wherein, the main processor receiving the sidetone signal and the handset signal is specifically:
the master processor receiving the microphone’s sidetone signal from the first audio input port through the first audio signal channel, and receiving the handset signal from said second audio input port through the second audio signal channel.
4. A terminal for implementing call recording, wherein, the terminal comprises: an establishment module, a master processor, and a slave processor; wherein,
the establishment module is configured to establish an audio signal channel between the master processor and the slave processor of the mobile terminal;
the main processor is configured to receive the mobile terminal microphone’s sidetone signal and handset signal sent from the slave processor through the audio signal channel and record;
the slave processor is configured to send the mobile terminal microphone’s sidetone signal and handset signal to the master processor through the audio signal channel established by the establishment module;
wherein the audio signal channel is specifically:
an audio signal channel is configured to send the slave processor’s sidetone signal to the master processor, and another audio signal channel is configured to send the slave processor’s handset signal to the master processor.
5. The terminal of claim 4, wherein, the master processor further comprises:
a recording module, which is configured to record the received sidetone signal and handset signal.
6. The terminal of claim 5, wherein, the audio signal channel is specifically:
an audio signal channel is configured to send the slave processor’s sidetone signal to the master processor, and another audio signal channel is configured to send the slave processor’s handset signal to the master processor.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
1. An extracellular matrix (ECM) valve conduit for regenerating a semi-lunar valve within a heart of a subject, comprising:
a tubular valve construct comprising an acellular extracellular matrix (ECM) material, said tubular valve construct having a longitudinal axis and an outer wall, said tubular valve construct further comprising a lumen, an inlet portion and an outlet portion, said inlet portion comprising an inner layer and an outer layer, said inner layer of said inlet portion comprising a top edge, said outlet portion comprising an inner layer and outer layer,
said outer layers of said inlet and outlet portions defining said outer wall of said tubular valve construct,
said outlet portion defining an outlet in fluid communication with said lumen of said tubular valve construct, said inlet portion defining an inlet in fluid communication with the lumen of said tubular valve construct,
said inner layer being positioned within said lumen of said tubular valve conduit, said inner layer of said outlet portion being inwardly reflected within said lumen of said tubular valve construct, wherein said inner layer top edge is disposed proximate said tubular valve construct inlet,
said inner layer of said outlet portion being attached to said outer layer solely at first, second, third and fourth attachment points adjacent said inner layer top edge, said first, seconds third and fourth attachment points being equally spaced along an outer circumference of said tubular valve conduit and positioned on a common plane that is perpendicular to said tubular valve construct longitudinal axis, wherein said inner and outer layers are not secured to each other proximate said inlet,
wherein a commissure-promoting portion is formed on said inner layer of said inlet portion of said tubular valve construct and a sinus-promoting portion is formed on said outer wall of said tubular valve construct, and
wherein after implantation into the heart of the subject, the valve conduit acts to regenerate leaflets of the semi-lunar valve.
2. The ECM valve conduit of claim 1, wherein said ECM material comprises extracellular matrix tissue from a mammalian tissue source, said mammalian tissue source being selected from the group consisting of stomach submucosa, small intestine submucosa, large intestine tissue, bladder tissue, liver tissue, heart tissue, lung tissue, kidney tissue, pancreatic tissue, prostate tissue, fetal tissue, a placenta, a ureter, vein, artery and tissue surrounding growing bone.
3. The ECM valve conduit of claim 2, wherein said ECM material includes an additional pharmacological agent.
4. The ECM valve conduit of claim 3, wherein said pharmacological agent comprises an anti-inflammatory agent.
5. The ECM valve conduit of claim 3, wherein said pharmacological agent comprises an anti-arrhythmic agent.
6. The ECM valve conduit of claim 3, wherein said pharmacological agent comprises a statin selected from the group consisting of atorvastatin, cerivastatin, fluvastatin, lovastatin, mevastatin, pitavastatin, pravastatin, rosuvastatin and simvastatin.
7. The ECM valve conduit of claim 3, wherein said pharmacological agent comprises a growth factor selected from the group consisting of a platelet derived growth factor (PDGF), epidermal growth factor (EGF), transforming growth factor alpha (TGF-alpha), transforming growth factor beta (TGF-beta), basic fibroblast growth factor (bFGF), vascular epithelial growth factor (VEGF), hepatocyte growth factor (HGF), insulin-like growth factor (IGF), and placental growth factor (PGF).